Strata Critical Medical, Inc. logo

SRTAWStrata Critical Medical, Inc.

NASDAQ

$0.00

-$0.00 (-88.68%)

Strata Critical Medical, Inc. (SRTAW) common stock listed on NASDAQ. It is led by Melissa M. Tomkiel J.D., based in 31 Hudson Yards, New York, NY, United States, 10001, with about 327 employees. Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

Latest reported SRTAW revenue for 2025-09-30 was $49.3M. Net income was $57.4M. Revenue was down 30.4% from 2025-06-30 to 2025-09-30.

Use this SRTAW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SRTAW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SRTAW SEC filings page. Lician reads the product cache first so this HTML stays unique to Strata Critical Medical, Inc. even when a live quote feed is slow.

About Strata Critical Medical, Inc.

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

SRTAW Key Statistics

Market Cap

$0.00M

Volume

638,916

Previous Close

$0.01

Day Range

$0.00$0.00

00

EPS

-$0.35

Revenue

$248.69M

Net Income

-$27.31M

Gross Profit

$0.00

Free Cash Flow

$0.00

Revenue Growth

+10.4%

Profit Margin

-11.0%

Employees

327

SRTAW Financials

Annual income statement in USD. Latest reported periods first.

SRTAW annual income statement across FY2024, FY2023, FY2022, FY2021
LineFY2024FY2023FY2022FY2021
Revenue$248.69M$225.18M$146.12M$24.62M
Cost of Revenue$0.00$0.00$0.00$0.00
Gross Profit$0.00$0.00$0.00$0.00
Operating Income$0.00$0.00$0.00$0.00
Net Income-$27.31M-$56.08M-$27.26M$772.00K
EPS (Diluted)-$0.35-$0.76-$0.38$0.01

Total Assets

$256.68M

Total Debt

$0.00

Shareholders' Equity

$0.00

Cash & Equivalents

$18.38M

Operating Cash Flow

-$2.52M

Free Cash Flow

$0.00

Strata Critical Medical, Inc. Company Information

Co- CEO, General Counsel, Corporate Secretary & Director
Melissa M. Tomkiel J.D.
Headquarters
31 Hudson Yards, New York, NY, United States, 10001
Phone
585 301 1762
IPO / Founded
2025-08-29
Data Updated:

Upcoming Events for SRTAW